By Allison Proffitt

Pathway Genomics has launched its BRCA True test for BRCA 1 and BRCA 2 and its BRCA One for One program, hoping to offer the industry’s best BRCA genetic test and make it accessible to a wide range of women.

The company believes the One for One program to be rare in health care. “We thought a lot about it and we talked to a lot of global patient advocacy organizations and we thought… for every test that was ordered, we can donate a test to someone in need,” Ardy Arianpour, Chief Strategy Officer for Pathway Genomics told Bio-IT World.

Pathway is partnering with eight advocacy groups representing an international patient population: Susan G. Koman for the Cure, Bright Pink, Living Beyond Breast Cancer, National Ovarian Cancer Coalition, Young Survival Coalition, Foundation for Women’s Cancer, Facing Our Risk of Cancer, and Sharsheret.